Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus
Authors
Keywords
-
Journal
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
Volume 59, Issue -, Pages -
Publisher
FapUNIFESP (SciELO)
Online
2017-11-01
DOI
10.1590/s1678-9946201759067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Recommendations on Treatment of Hepatitis C 2016
- (2017) JOURNAL OF HEPATOLOGY
- Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
- (2016) L.P. Zanaga et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)
- (2016) Vincent Leroy et al. HEPATOLOGY
- The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
- (2016) Christoph Sarrazin JOURNAL OF HEPATOLOGY
- Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin
- (2015) P. Monje-Agudo et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Hepatitis C Virus
- (2015) Javier Ampuero et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
- (2015) David R. Nelson et al. HEPATOLOGY
- Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
- (2015) HEPATOLOGY
- Therapy for hepatitis C genotype 3: moving forward
- (2015) M. Buti et al. JOURNAL OF VIRAL HEPATITIS
- Factors Associated with Failure to Achieve SVR in Hepatitis C Genotype 3 Patients Within an Integrated Care Delivery System
- (2015) T. Craig Cheetham et al. Journal of Managed Care & Specialty Pharmacy
- Review article: HCV genotype 3 - the new treatment challenge
- (2014) J. Ampuero et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global distribution and prevalence of hepatitis C virus genotypes
- (2014) Jane P. Messina et al. HEPATOLOGY
- Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’
- (2014) Maria Buti et al. Expert Review of Gastroenterology & Hepatology
- High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials
- (2012) Patrick Marcellin et al. HEPATOLOGY
- Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
- (2009) Maria Grazia Rumi et al. GASTROENTEROLOGY
- Clinical Significance of Metabolic Syndrome in the Setting of Chronic Hepatitis C Virus Infection
- (2008) Ibrahim A. Hanouneh et al. Clinical Gastroenterology and Hepatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search